Research Summary

Nancy Hessol is an epidemiologist whose research interests include HIV disease progression and mortality, HIV-related malignancies, and human Papillomavirus infection. She has more than 30 years of experience directing epidemiologic studies of HIV/AIDS and of health disparities. Professor Hessol has extensive experience working on multisite research projects, analyzing complex databases, and has authored numerous publications. She is considered an international expert on HIV disease progression, with a special emphasis on HIV-related malignancies. From 2001 to 2014 and from 2016 to the present, Professor Hessol has Chaired the NIH sponsored Women’s Interagency HIV Study Cancer & Pathology Working Group. She also has a strong interest in salary equity and is the statistical analyst for the UCSF School of Medicine and School of Pharmacy Faculty Salary Equity Review (FSER), which examines equity among females and under-represented minorities. In 2016, she was selected as the School of Pharmacy senior faculty Equity Advisory to help ensure excellence, equity, and diversity for all recruited faculty at UCSF.

Nancy Hessol received a Master’s of Science in Public Health in epidemiology from UCLA’s School of Public Health in 1982 and following graduation worked on occupational, environmental, and reproductive epidemiological studies at the Hanford Nuclear facilities in Richland, Washington. In 1986 and with a strong desire to work with the growing AIDS epidemic, Ms. Hessol joined the San Francisco Department of Public Health where her research focused on HIV disease progression. Seven years later, she began employment at UCSF where she is currently a Professor in the Departments of Clinical Pharmacy and of Medicine. In 2003, she received a UCSF Champion of Diversity award for her research activities in health disparities. In March 2010, she received the Lifetime Achievement Award from the UCLA School of Public Health and was inducted into the UCLA School of Public Health Hall of Fame. She is a ten-time winner of the Apple for Teachers Award given by the Dean of the UCSF School of Pharmacy.

Nancy Hessol has been the course director for the School of Pharmacy Research Seminar, Study Design and Evaluation, and co-director for Foundations I. She also serves on the School of Pharmacy Curriculum Transformation Committee, the Admissions Committee, and Student Progress Committee. She is also an active member on the Academic Senate Committee for Equal Opportunity.

Education

Hampshire College, Amherst, Massachusetts B. A., 1979, Biochemistry
University of California, Los Angeles M. S. P. H., 1982, Epidemiology

Honors & Awards

  • 2003
    Champion of Diversity Award, UCSF
  • 2009
    Outstanding Public Service Certificate of Appreciation, Director, San Francisco Department of Public Health
  • 2009
    Certificate of Honor for Service to the San Francisco Public Health Foundation, Mayor, City and County of San Francisco
  • 2010
    Lifetime Achievement Award, UCLA, School of Public Health
  • 2010
    Hall of Fame Induction, UCLA, School of Public Health
  • 2011-2015
    Apple for Teachers Award, Dean, UCSF School of Pharmacy

Selected Publications

  1. Schwarcz S, Hessol NA, Spinelli MA, Hsu LC, Wlodarczyk D, Tulsky J, Newman MD, Buchbinder SP Sensitivity and Specificity of the National Death Index for Multiple Causes of Death in People With HIV.  View on PubMed
  2. Hessol NA, Barrett BW, Margolick JB, Plankey M, Hussain SK, Seaberg EC, Massad LS Risk of smoking-related cancers among women and men living with and without HIV.  View on PubMed
  3. Appa A, Rowe C, Hessol NA, Coffin P Beyond Overdose: Drug-Related Deaths in People With and Without HIV in San Francisco, 2007-2018.  View on PubMed
  4. Strickler HD, Keller MJ, Hessol NA, Eltoum IE, Einstein MH, Castle PE, Massad LS, Flowers L, Rahangdale L, Atrio JM, Ramirez C, Minkoff H, Adimora AA, Ofotokun I, Colie C, Huchko MJ, Fischl M, Wright R, D'Souza G, Leider J, Diaz O, Sanchez-Keeland L, Shrestha S, Xie X, Xue X, Anastos K, Palefsky JM, Burk RD Primary HPV and Molecular Cervical Cancer Screening in US Women Living with HIV.  View on PubMed
  5. Silverberg MJ, Leyden W, Hernández-Ramírez RU, Qin L, Lin H, Justice AC, Hessol NA, Achenbach CJ, D'Souza G, Engels EA, Althoff KN, Mayor AM, Sterling TR, Kitahata MM, Bosch RJ, Saag MS, Rabkin CS, Horberg MA, Gill MJ, Grover S, Mathews WC, Li J, Crane HM, Gange SJ, Lau B, Moore RD, Dubrow R, Neugebauer RS, Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV.  View on PubMed
  6. Zepf R, Greene M, Hessol NA, Johnson MO, Santos GM, John MD, Dawson-Rose C Syndemic conditions and medication adherence in older men living with HIV who have sex with men.  View on PubMed
  7. Bacon O, Chin J, Cohen SE, Sachdev D, Coffey S, Scheer S, Hessol NA, Buchbinder S, Havlir DV, Hsu L Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco.  View on PubMed
  8. Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Hessol NA, Achenbach CJ, Brooks JT, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Patel P, Rabkin CS, Rachlis A, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R Association of Immunosuppression and Human Immunodeficiency Virus (HIV) Viremia With Anal Cancer Risk in Persons Living With HIV in the United States and Canada.  View on PubMed
  9. Bourgeois JA, John M, Zepf R, Greene M, Frankel S, Hessol NA Functional deficits and other psychiatric associations with abnormal scores on the Montreal Cognitive Assessment (MoCA) in older HIV-infected patients.  View on PubMed
  10. Hessol NA, Eng M, Vu A, Pipkin S, Hsu LC, Scheer S A longitudinal study assessing differences in causes of death among housed and homeless people diagnosed with HIV in San Francisco.  View on PubMed
  11. Castle PE, Burk RD, Massad LS, Eltoum IE, Hall CB, Hessol NA, Anastos K, Xie X, Minkoff H, Xue X, D'Souza G, Flowers L, Colie C, Rahangdale L, Fischl MA, Palefsky JM, Strickler HD Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study.  View on PubMed
  12. Johnson KA, Hessol NA, Kohn R, Nguyen TQ, Mara ES, Hsu L, Scheer S, Cohen SE HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.  View on PubMed
  13. Spinelli MA, Hessol NA, Schwarcz S, Hsu L, Parisi MK, Pipkin S, Scheer S, Havlir D, Buchbinder SP Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city.  View on PubMed
  14. Lin C, Slama J, Gonzalez P, Goodman MT, Xia N, Kreimer AR, Wu T, Hessol NA, Shvetsov Y, Ortiz AP, Grinsztejn B, Moscicki AB, Heard I, Del Refugio González Losa M, Kojic EM, Schim van der Loeff MF, Wei F, Longatto-Filho A, Mbulawa ZA, Palefsky JM, Sohn AH, Hernandez BY, Robison K, Simpson S, Conley LJ, de Pokomandy A, van der Sande MAB, Dube Mandishora RS, Volpini LPB, Pierangeli A, Romero B, Wilkin T, Franceschi S, Hidalgo-Tenorio C, Ramautarsing RA, Park IU, Tso FK, Godbole S, D'Hauwers KWM, Sehnal B, Menezes LJ, Heráclio SA, Clifford GM Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.  View on PubMed
  15. Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Althoff KN, Achenbach CJ, Hessol NA, D'Souza G, Gebo KA, Gill MJ, Grover S, Horberg MA, Li J, Mathews WC, Mayor AM, Park LS, Rabkin CS, Salters K, Justice AC, Moore RD, Engels EA, Silverberg MJ, Dubrow R Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study.  View on PubMed
  16. Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Anastos K, Xie X, Minkoff H, Xue X, Reimers LL, Kuniholm M, D'Souza G, Colie C, Aouizerat B, Palefsky JM, Strickler HD Racial differences in human papilloma virus types amongst United States women with HIV and cervical precancer.  View on PubMed
  17. Cook JA, Burke-Miller JK, Steigman PJ, Schwartz RM, Hessol NA, Milam J, Merenstein DJ, Anastos K, Golub ET, Cohen MH Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV.  View on PubMed
  18. Hessol NA, Whittemore H, Vittinghoff E, Hsu LC, Ma D, Scheer S, Schwarcz SK Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.  View on PubMed
  19. Gradissimo A, Lam J, Attonito JD, Palefsky J, Massad LS, Xie X, Eltoum IE, Rahangdale L, Fischl MA, Anastos K, Minkoff H, Xue X, D'Souza G, Flowers LC, Colie C, Shrestha S, Hessol NA, Strickler HD, Burk RD Methylation of High-Risk Human Papillomavirus Genomes Are Associated with Cervical Precancer in HIV-Positive Women.  View on PubMed
  20. Yanik EL, Hernández-Ramírez RU, Qin L, Lin H, Leyden W, Neugebauer RS, Horberg MA, Moore RD, Mathews WC, Justice AC, Hessol NA, Mayor AM, Gill MJ, Brooks JT, Sun J, Althoff KN, Engels EA, Silverberg MJ, Dubrow R Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada.  View on PubMed

Go to UCSF Profiles, powered by CTSI